News

Shahin Davoudpour, PhD, MA, MA, discusses the challenges associated with access to and persistence with pre-exposure ...
Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...
In 2021, approval of cabotegravir (Apretude) as the first long-acting PrEP option provided patients an option to move from ...
The NHS is calling for 200,000 new donors to come forward as it warns of a "challenging" blood supply shortage. Currently ...
Quezon City recorded 421 new human immunodeficiency virus (HIV) cases from January to May this year. That is over 7.7 percent ...
FA new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration (FDA) later this month.
A Houston physician has sued the federal government to cut benefits through the Affordable Care Act that requires access to ...
The PURPOSE trials illuminated the ways in which lenacapavir could be used as a means of pre-exposure prophylaxis effectively, but also featured several adverse events.
On Monday, analysts at Morgan Stanley reiterated their Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD), while ...
Here’s a look at the origins, treatments and global response to HIV and AIDS. Facts HIV stands for human immunodeficiency virus. AIDS stands for acquired immunodeficiency syndrome. HIV/AIDS is spread ...
China CDC Key Laboratory of Environment and Population Health, National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing 100021, China ...